Contemporary OB/GYN week in review: Ovarian cancer, postpartum hemorrhage, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: Ovarian cancer, postpartum hemorrhage, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, July 15 - Friday, July 19, 2024), and click each link to read and watch anything you may have missed.
1.) Study links endometriosis to increased risk of ovarian cancer
Women with ovarian endometriomas or deep infiltrating endometriosis face a significantly higher risk of ovarian cancer, highlighting the need for increased awareness and research into these associations.
Click here for the full article.
2.) Postpartum hemorrhage risk reported higher in nulliparous women
A recent study reveals that nulliparous women have a higher incidence of postpartum hemorrhage compared to multiparous women, highlighting the need for targeted prediction models and early intervention strategies.
Click here for the full article.
3.) cUTI Roundtable: Is Resistance Increasing?
The second episode in our series looks to address clinical management in a time when antimicrobial resistance appears to be growing.
Click here for the full article.
4.) Maternal BMI, not glucose levels, linked to mid-childhood educational outcomes
A recent study reveals that maternal body mass index during pregnancy is associated with children's mid-childhood educational attainment, whereas maternal glucose status shows no significant impact.
Click here for the full article.
5.) Global progress in neonatal tetanus elimination from 2000 to 2022
Incorporating maternal and neonatal tetanus elimination strategies into national immunization activities is crucial for sustaining elimination and reducing neonatal mortality worldwide, as highlighted by the latest CDC report.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
